Leadership
- Dr David Béchard, 36 – Founder, President, COO
- 10 years of entrepreneurial experience (Endotis Pharma, LSO) and finance/strategy consulting (OC&C Strategy) in biotech-pharma / private equity.
- PhD in Immunology-Oncology (Inserm / Pasteur Institute) and 3rd cycle in strategy/finance (HEC Paris).
- Vice-President of the BoD of the pole of competitiveness Atlanpole Biotherapy.
- Dr Yannick Jacques, 60 – Founder, CSO
- 35 years of experience in academic research (CNRS, INSERM).
- Director of the Cancer Research Center of Nantes-Angers (INSERM U892), University of Nantes, CHU Hotel Dieu.
- Polytechnician, PhD in Chemistry-Biology.
- Dr Didier Coquoz , 50, CDO/BD&L
- 20 years of experience in therapies and biotech companies development on both sides of the Atlantic, involved in the development of 24 drugs from lead up to and including registration.
- Serial entrepreneur with large pharma/finance network.
- PhD in clinical pharmacology (Geneva Medicine Faculty), Pharm D (Geneva Sciences Faculty).
- Dr Guy de Martynoff, 53, CTO
- 20 years of experience in biopharmaceutical production (Innogenetics, Bioprotein, Meristem Therapeutics, DMS biotechnology).
- PhD in Chemistry-Molecular Biology (Free University Brussels) with 2 post-doctorates (GSK Bio, Rixensart-BE and E.M.B.L., Heidelberg-DE).
- Remora Partners (Switzerland), M&A, BD&L, support
- Institute Gustave Roussy (Villejuif), European Hospital Pompidou (Paris), Cancer Research centers (Nantes & Montpellier), SCIENTIFIC ADVISORY BOARD MEMBERS